About Us

When the COVID-19 outbreak began in the United States, Rise Solutions was in a position to leverage decades of contacts and experience to provide much needed, reliable and sustainable, supply chain support to the provision of COVID-19 testing solutions and Personal Protective Equipment (PPE), specifically nitrile gloves, as well as utilize our technical and commercial experience in molecular genetics lab development and management for RT-PCR testing needs that are currently overwhelming diagnostic testing capacities nationally.  

Rise Solutions, based on the Gulf Coast, maintains very close involvement through ownership in a genetics PCR, diagnostic laboratory, maintains close relationships with COVID-19 Rapid Antigen Test Kit manufacturing contract owners and suppliers, and nitrile glove manufacturers .  

PRODUCTS CUSTOMIZED FOR YOUR NEED:

 - COVID-19 RAPID ANTIGEN KITS - OTC

 - COVID-19 RAPID ANTIGEN KITS - Point Of Care

 - RT-PCR Testing

 - Nitrile Medical Exam Gloves

RELIABLE PROVISION, FROM COVID-19 TESTING TO PERSONAL PROTECTION EQUIPMENT (PPE), FROM SOURCE TO DELIVERY.  

From the beginning of the COVID-19 pandemic, the Rise team, through PCR lab involvement, has been involved in developing solutions to mitigate COVID-19 exposure and spread risks in the workplace.  We bring this experience to help you both determine your COVID testing needs and which COVID testing solution works best.

Working closely with trusted manufacturing sources and diagnostic laboratories, Rise will assist you in not just determining the best testing approach for your organization, but which COVID-19 testing method and solution works best for your workflow and budget.

COVID-19 TESTING:  RELIABLE SOLUTIONS FOR TIMELY AND PRECISE TESTING, FROM RAPID ANTIGEN KITS TO RT-PCR.

CV19 PCR diagnostic laboratory testing has become a critical part of the lives of many, from clinic testing needs to work site safety needs.  Our team is invested in, consulting for, and engaged in the management of PCR-based diagnostic laboratories as well as engaged in the development and clinical testing of both new molecular diagnostic testing platforms and instruments.  We have been directly invested in the provision of solutions for the CV19 testing crisis.  We innately appreciate the gaps in RT-PCR diagnostic testing capacities in the U.S. and the need for Rapid Point of Care testing, and we understand the technical and logistical requirements.

Regarding PPE, our current focus is on the provision of quality protective nitrile gloves for a fair market price.  Other PPE are readily available upon request.